Cushing's syndrome classification: Difference between revisions

Jump to navigation Jump to search
 
(16 intermediate revisions by 4 users not shown)
Line 2: Line 2:
{{Cushing's syndrome}}
{{Cushing's syndrome}}


{{CMG}}
{{CMG}} {{AE}} {{MJK}} {{MMF}}


==Overview==
==Overview==
Cushing's syndrome may be classified according to the source of [[cortisol]] into four subtypes; [[Endogenous]], [[exogenous]], [[familial]] Cushing's Syndrome, and pseudo-Cushing’s syndrome.


==Classification==
Cushing's syndrome is classified into two main subtypes:<ref name="pmid26004339">{{cite journal |vauthors=Lacroix A, Feelders RA, Stratakis CA, Nieman LK |title=Cushing's syndrome |journal=Lancet |volume=386 |issue=9996 |pages=913–27 |year=2015 |pmid=26004339 |doi=10.1016/S0140-6736(14)61375-1 |url=}}</ref><ref name="pmid25480800">{{cite journal |vauthors=Raff H, Carroll T |title=Cushing's syndrome: from physiological principles to diagnosis and clinical care |journal=J. Physiol. (Lond.) |volume=593 |issue=3 |pages=493–506 |year=2015 |pmid=25480800 |pmc=4324701 |doi=10.1113/jphysiol.2014.282871 |url=}}</ref><ref name="pmid24423978">{{cite journal |vauthors=Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD |title=Adrenocortical carcinoma |journal=Endocr. Rev. |volume=35 |issue=2 |pages=282–326 |year=2014 |pmid=24423978 |pmc=3963263 |doi=10.1210/er.2013-1029 |url=}}</ref>


==Classification==
*'''Exogenous:'''
There are two types of Cushing’s syndrome: exogenous and endogenous. In endogenous disease, excess cortisol production ''within'' the body is the cause, whilst in exogenous disease the causal factor is typically steroid medication  (i.e. it originates ''outside'' the body) mimicing cortisol's activity. The signs and symptoms are therefore virtually identical, aside from those induced by ACTH in pituitary-dependent disease and ectopic ACTH-producing tumours (such as hyperpigmentation). The exogenous route is ''by far'' the most commonly taken in Cushing’s syndrome (a fact that all too many seem to forget). Examples of such exogenous steroid medications are those used to treat inflammatory disorders such as [[asthma]] and [[rheumatoid arthritis]], or to suppress the immune system after an organ transplant. This type of Cushing’s syndrome is temporary and goes away after the patient has finished taking the cortisol-like medications. Endogenous Cushing’s syndrome is unusual, it usually comes on slowly and can be difficult to diagnose.
:*Also called [[iatrogenic]] Cushing's syndrome. It is due to [[chronic]] [[glucocorticoids|glucocorticoid]] intake for [[inflammatory]] conditions, such as [[allergies]], [[asthma]], [[autoimmune diseases]], and after [[organ transplantation]].
 
*'''Endogenous:'''
::*[[Benign]] [[tumors]]:
:::*[[Pituitary adenoma]]
:::*[[Adrenal adenoma]]
:::*[[Adrenal hyperplasia|Adrenal micronodular hyperplasia]]
:::*[[Ectopic]] [[adenomas]], which are originated from locations other than the [[pituitary]] or [[adrenal glands]], mostly from the [[lungs]], [[pancreas]], [[thyroid]], or [[thymus]].
::*[[Malignant]] tumors:
:::*[[Adrenal cancer]]
:::*Cancer in places other than the [[pituitary]] or [[adrenal glands]], mostly in the [[lungs]], [[pancreas]], [[thyroid]], or [[thymus]]   
 
*'''Familial Cushing's Syndrome:'''
:*Patients with rare [[genetic]] diseases like [[multiple endocrine neoplasia type 1]] (MEN 1) and primary pigmented [[micronodular adrenal disease]] are more susceptible to develop [[tumors]] in [[glands]] that affect [[cortisol]] secretion. As a result, these patients will develop Cushing's syndrome.  
 
*'''Pseudo-Cushing’s Syndrome:'''
:*It is due to [[alcoholism]], [[depression]] or other [[psychiatric disorders]], [[obesity]], [[pregnancy]], and poorly controlled [[diabetes]].


==References==
==References==

Latest revision as of 18:25, 20 October 2017

Cushing's syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cushing's syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cushing's syndrome classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cushing's syndrome classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cushing's syndrome classification

CDC on Cushing's syndrome classification

Cushing's syndrome classification in the news

Blogs on Cushing's syndrome classification

Directions to Hospitals Treating Cushing's syndrome

Risk calculators and risk factors for Cushing's syndrome classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Furqan M M. M.B.B.S[3]

Overview

Cushing's syndrome may be classified according to the source of cortisol into four subtypes; Endogenous, exogenous, familial Cushing's Syndrome, and pseudo-Cushing’s syndrome.

Classification

Cushing's syndrome is classified into two main subtypes:[1][2][3]

  • Exogenous:
  • Endogenous:
  • Familial Cushing's Syndrome:
  • Pseudo-Cushing’s Syndrome:

References

  1. Lacroix A, Feelders RA, Stratakis CA, Nieman LK (2015). "Cushing's syndrome". Lancet. 386 (9996): 913–27. doi:10.1016/S0140-6736(14)61375-1. PMID 26004339.
  2. Raff H, Carroll T (2015). "Cushing's syndrome: from physiological principles to diagnosis and clinical care". J. Physiol. (Lond.). 593 (3): 493–506. doi:10.1113/jphysiol.2014.282871. PMC 4324701. PMID 25480800.
  3. Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD (2014). "Adrenocortical carcinoma". Endocr. Rev. 35 (2): 282–326. doi:10.1210/er.2013-1029. PMC 3963263. PMID 24423978.


Template:WH Template:WS